Skip to main content

Table 5 Premiums charged and activity per vaccine

From: An evaluation of South Africa’s public–private partnership for the localisation of vaccine research, manufacture and distribution

Vaccine type

Activity

Agreed premium

Calculated premium

TT

Cold chain distribution

15%

14%

HBV (Adult and Paediatric)

Packaging, labelling and distribution

20%

17%

OPV

Cold chain distribution

15%

14%

Measles

Cold chain distribution

15%

14%

BCG

Packaging, labelling and distribution

20%

17%

Td

Cold chain distribution

15%

14%

PCV

Packaging, labelling and distribution

10%

17%

Rota

Cold chain distribution

10%

14%

Pentaxim

Distribution

15%

12%

HPV

Distribution

15%

12%

  1. BCG Bacillus Calmette–Guérin, HBV hepatitis B, HPV human papillomavirus, OPV oral poliovirus, PCV Pneumococcal conjugate vaccine, Rota rotavirus vaccine, Td tetanus diphtheria, TT tetanus toxoid